These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19158035)

  • 1. Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer.
    Ademuyiwa FO; Miller KD
    Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S151-6. PubMed ID: 19158035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic therapies in breast cancer.
    Sarmiento R; D'Andrea MR; Cacciamani F; Salerno F; Gasparini G
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1334-45. PubMed ID: 19943205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis inhibitors in the management of breast cancer.
    Bossung V; Harbeck N
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):79-86. PubMed ID: 19952746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic strategies, compounds, and early clinical results in breast cancer.
    Morabito A; Sarmiento R; Bonginelli P; Gasparini G
    Crit Rev Oncol Hematol; 2004 Feb; 49(2):91-107. PubMed ID: 15012971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer: the role of angiogenesis and antiangiogenic therapy.
    Miller KD; Dul CL
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):1071-86, ix. PubMed ID: 15474336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment.
    Gagne P; Akalu A; Brooks PC
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic therapy in the management of breast cancer.
    Wu Y; Sun WL; Feng JF
    Asia Pac J Clin Oncol; 2013 Jun; 9(2):110-6. PubMed ID: 22898270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic strategies in breast cancer management.
    Giovannini M; Aldrighetti D; Zucchinelli P; Belli C; Villa E
    Crit Rev Oncol Hematol; 2010 Oct; 76(1):13-35. PubMed ID: 20702105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting angiogenesis with integrative cancer therapies.
    Yance DR; Sagar SM
    Integr Cancer Ther; 2006 Mar; 5(1):9-29. PubMed ID: 16484711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
    Lyons JM; Anthony CT; Thomson JL; Woltering EA
    Ann Surg Oncol; 2008 Dec; 15(12):3407-14. PubMed ID: 18795370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of antiangiogenic therapy with other modalities.
    O'Reilly MS
    Cancer J; 2002; 8 Suppl 1():S89-99. PubMed ID: 12075706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenesis: the fifth cancer treatment modality?
    Camp-Sorrell D
    Oncol Nurs Forum; 2003; 30(6):934-44. PubMed ID: 14603351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
    Cao Y
    Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic events in patients with cancer receiving antiangiogenesis agents.
    Zangari M; Fink LM; Elice F; Zhan F; Adcock DM; Tricot GJ
    J Clin Oncol; 2009 Oct; 27(29):4865-73. PubMed ID: 19704059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?
    Miller KD
    Breast Cancer Res; 2004; 6(3):128-32. PubMed ID: 15084233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic therapy for cancer: an update.
    Shojaei F; Ferrara N
    Cancer J; 2007; 13(6):345-8. PubMed ID: 18032969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic drugs in ovarian cancer.
    Markman M
    Expert Opin Pharmacother; 2009 Oct; 10(14):2269-77. PubMed ID: 19671017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targets for breast cancer therapy and prevention.
    Bange J; Zwick E; Ullrich A
    Nat Med; 2001 May; 7(5):548-52. PubMed ID: 11329054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy.
    Mazeron R; Anderson B; Supiot S; Paris F; Deutsch E
    Cancer Treat Rev; 2011 Oct; 37(6):476-86. PubMed ID: 21546163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antiangiogenic drugs for the management of breast cancer: new approaches for an old issue?
    Bozza C; Fontanella C; Buoro V; Mansutti M; Aprile G
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):251-65. PubMed ID: 25597501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.